Association of an anaplastic lymphoma kinase pathway signature with cell de‐differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer

@article{Liu2020AssociationOA,
  title={Association of an anaplastic lymphoma kinase pathway signature with cell de‐differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer},
  author={D. Liu and Y. Wu},
  journal={Cancer Communications},
  year={2020},
  volume={40},
  pages={422 - 434}
}
  • D. Liu, Y. Wu
  • Published 2020
  • Medicine
  • Cancer Communications
Aberrant activation of anaplastic lymphoma kinase (ALK) signaling has been found to be involved in the tumorigenesis of multiple types of cancer. The aim of this study was to determine the role of this pathway in the pathogenesis of breast cancer. 
1 Citations
Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis
  • PDF

References

SHOWING 1-10 OF 51 REFERENCES
Role and targeting of anaplastic lymphoma kinase in cancer
  • 22
RAS-MAPK in ALK targeted therapy resistance
  • 9
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
  • 4,173
  • PDF
Anaplastic lymphoma kinase is expressed in different subtypes of human breast cancer.
  • 49
...
1
2
3
4
5
...